New drug enters final testing to control devastating liver virus
Disease control
Not yet recruiting
This study is testing whether a new drug called Hepalatide (L47) can help control chronic hepatitis D, a serious liver infection. About 150 patients will receive either the drug or a placebo for 48 weeks, while doctors monitor their virus levels and liver health. The goal is to s…
Phase: PHASE3 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC